A direct-to-consumer brand is judged on the pages its patients see: the claims on the landing page, the terms at the checkout, and who the site says is prescribing. These articles cover the website, marketing and disclosure requirements that decide a brand's application before anyone looks at its clinical model.
Direct-to-consumer telehealth brands
Certification attaches to a domain, so a rebrand, a domain migration or a corporate restructure changes the thing that was certified, and a brand that redirects its traffic before telling anyone ends up advertising a domain that appears in no LegitScript listing.
· 5 min read
Direct-to-consumer telehealth brands
A LegitScript reviewer can reach the confirmation email, the patient portal, the dosing instructions and the card that ships in the box, and those four surfaces are usually written by different people to no standard at all, which is where a corrected claim most often survives.
· 5 min read
Direct-to-consumer telehealth brands
A patient testimonial stating a result is an effectiveness claim about the product that patient received, which for a compounded preparation is a claim with no review behind it, and a LegitScript reviewer reads a five-star widget the same way it reads the headline above it.
· 5 min read
Direct-to-consumer telehealth brands
Peptides are the category where a LegitScript reviewer asks a structural question before a marketing one, because the first thing to establish is what the substance is and on what basis a compounder may lawfully prepare it, and research-use framing on a consumer site answers neither.
· 5 min read
Direct-to-consumer telehealth brands
Testosterone, menopause and thyroid brands are certified routinely, but the category combines compounded preparations, controlled substances in some formulations and outcome marketing aimed at ageing, which is why a LegitScript reviewer reads the optimisation language before anything else.
· 5 min read
Direct-to-consumer telehealth brands
Subscription telehealth is scrutinised from four directions at once, by the LegitScript reviewer, the card networks, consumer protection regulators and the patient's own bank, and the same six disclosures satisfy all four while cutting the dispute rate an acquirer is underwriting.
· 5 min read
Direct-to-consumer telehealth brands
Affiliate networks and healthcare marketplaces increasingly screen telehealth offers on LegitScript certification before diligence opens, which turns a missing credential into a channel that simply never converts rather than into a rejection anybody tells you about.
· 5 min read
Direct-to-consumer telehealth brands
Men's health brands are certified routinely, but ED and hair-loss categories draw a closer review of three things in particular: whether a genuine prescribing decision happens, whether the product is described accurately, and whether a subscription can actually be cancelled.
· 5 min read
Direct-to-consumer telehealth brands
Every FDA warning letter issued to a telehealth or compounding company over compounded GLP-1 marketing turns on how the product was described, which makes the sentence under the product photograph the single most reviewed asset a weight management brand owns.
· 6 min read
Direct-to-consumer telehealth brands
A direct-to-consumer telehealth brand is reviewed on the pages its patients actually see, which is why brands with sound clinical models and credentialed prescribers still fail LegitScript review on a funnel domain nobody in the business considered part of the application.
· 6 min read